McAnaney Adam sold $63K of OSCR
McAnaney Adam (Chief Legal Officer) sold 2,794 shares of Oscar Health, Inc. (OSCR) at $22.45 on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates insider ownership records; because it is explicitly under a 10b5-1 plan, it is generally less informative about near-term company prospects.
Market read
For traders, this is a low-signal sentiment datapoint rather than a fundamental catalyst.
What to watch
The filing does not indicate motivation or whether other insiders/large holders are buying; also, the sale size is relatively small versus typical institutional float.
Background
This is an SEC Form 4 insider transaction for Oscar Health, Inc., reporting an officer’s direct open-market sale under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Oscar Health COO sold 2,794 shares in an open-market transaction disclosed on Form 4, updating insider ownership details for OSCR.
Likely limited immediate price impact; any effect is more sentiment/flow-driven than fundamental.
The filing specifies an open-market sale and a pre-arranged Rule 10b5-1 plan, which reduces the likelihood of information leakage, while still providing a fresh datapoint on insider activity.
Market effects
Minimal—this is company-specific insider activity with no stated sector/regulatory catalyst.
None.
None.
Counterpoint
If the market treats insider selling as bearish regardless of 10b5-1, OSCR could see short-lived negative sentiment despite the plan being pre-arranged.
Key entities
- issuerOscar Health, Inc.
Subject of the Form 4 insider transaction; insider sold shares under a Rule 10b5-1 plan.
- insiderMcAnaney Adam
Chief Legal Officer who executed the reported sale.
